Figure S1 from Cabozantinib Reverses Renal Cell Carcinoma–mediated Osteoblast Inhibition in Three-dimensional Coculture &lt;i&gt;In Vitro&lt;/i&gt; and Reduces Bone Osteolysis &lt;i&gt;In Vivo&lt;/i&gt;